eClinical Solutions
Powerful Visualizations and Analytics for Clinical Trials

Data’ is life sciences’ most valuable asset— companies rely on clinical trial data to support critical decisions-making. To date, systems that support clinical trials have focused on collecting, cleaning, tracking, and analyzing data from individual clinical trials. With today’s data explosion, however, it is imperative for the data coming from multiple trials to be aggregated and delivered in a concise, easily comprehensible manner to facilitate informed decision-making. Due to the large volume of clinical data in an organization, it can be quite challenging to manage it efficiently. eClinical Solutions was formed to assist life sciences organizations manage and maximize the value of their clinical research data. “We do so by making data acquisition, standardization, aggregation, and analysis absolutely simple and easy allowing stakeholders to efficiently analyze and act upon clinical trial data,” says Raj Indupuri, CEO, eClinical Solutions. “Our core directive is to empower clients to have complete access to all the collected data, allowing visualization and analysis across trials—down to the patient level.” eClinical has developed an end-to-end clinical data repository platform—elluminate—enabling both partners and data managers to see the collected data in a new light during the trial as well as after the database lock.

The platform empowers organizations through data aggregation and standardization, granting complete, seamless access to all data. Regardless of data sources or technologies utilized for data acquisition, eClinical’s innovative platform provides firms with complete access to all of their collected data—from cross trial/program views to the individual patient level—without long implementation times and at a fraction of the cost of enterprise data warehouses. Utilizing a private and secure cloud-based architecture, it offers scalable management of clinical data as well as efficient computing for data reporting and data analysis. Through elluminate, organizations can easily integrate clinical data—from any source—utilizing advanced Extraction, Transformation, and Load (ETL) technologies and frameworks, enabling standardization according to a defined data model based.

Our core directive is to empower clients to have complete access to all the collected data, allowing visualization and analysis across trials—down to the patient level

Once standardized, the data is centralized and ready for submission; it can also be easily accessed through integrated visualizations and business intelligence modules for cross-trial analysis.

In an illustration of the company’s data management techniques in clinical trials, eClinical assisted a biotech firm in Boston streamline two major areas of concern. The client’s data analytics vendor’s data reports did not correlate with the study results—affecting the credibility of the reports. Secondly, the clinical trial study builds performed for three protocols to capture data in an Electronic Data Capture (EDC) system was poorly designed. The eClinical team first focused on redesigning the studies to leverage the EDC capabilities—allowing them to recognize common data points and drastically reduce the number of electronic Case Report Forms (eCRF). The team then integrated the data from each of the three protocols and the legacy data from their previous programs, utilizing elluminate, to aggregate and analyze the study results. Today, the client has access to all their data and is able to analyze critical details through custom reports and visualizations at the click of a button, without requiring internal or external resources to configure the views.

eClinical Solutions, through its experience and innovation, aims to support life sciences organizations in managing and proactively making decisions regarding clinical trials. The company aspires to become a cornerstone for any firm’s clinical development plan by offering standardization of clinical data, processes, and technologies—providing them unparalleled access and views of all the clinical data.